Dauge MC - Search Results

1

Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome.

Baala L, Audollent S, Martinovic J, Ozilou C, Babron MC, Sivanandamoorthy S, Saunier S, Salomon R, Gonzales M, Rattenberry E, Esculpavit C, Toutain A, Moraine C, Parent P, Marcorelles P, Dauge MC, Roume J, Le Merrer M, Meiner V, Meir K, Menez F, Beaufrère AM, Francannet C, Tantau J, Sinico M, Dumez Y, MacDonald F, Munnich A, Lyonnet S, Gubler MC, Génin E, Johnson CA, Vekemans M, Encha-Razavi F, Attié-Bitach T. Baala L, et al. Among authors: dauge mc. Am J Hum Genet. 2007 Jul;81(1):170-9. doi: 10.1086/519494. Epub 2007 Jun 4. Am J Hum Genet. 2007. PMID: 17564974 Free PMC article.

2

Advantage of systematic random ultrasound-guided biopsies, measurement of serum prostate-specific antigen level and determination of prostate volume in the early diagnosis of prostate cancer.

Billebaud T, Villers A, Astier L, Boccon-Gibod L, Dauge MC, Sibert A, Baron JC, Delmas V, Boccon-Gibod L. Billebaud T, et al. Among authors: dauge mc. Eur Urol. 1992;21(1):6-14. doi: 10.1159/000474791. Eur Urol. 1992. PMID: 1376693

3

[The value of ultrasound-guided multiple systematic biopsies in the early diagnosis of cancer of the prostate].

Billebaud T, Sibert A, Dauge MC, Boccon-Gibod L, Baron JC, Villers A, Delmas V, Boccon-Gibod L. Billebaud T, et al. Among authors: dauge mc. Ann Urol (Paris). 1990;24(6):524-9. Ann Urol (Paris). 1990. PMID: 1702962 French.

4

[The correlation between the level of prostate-specific antigen and prostate gland volume in the early diagnosis of prostatic cancer].

Billebaud T, Astier L, Villers A, Boccon-Gibod L, Dauge MC, Sibert A, Baron JC, Delmas V, Boccon-Gibod L. Billebaud T, et al. Among authors: dauge mc. Prog Urol. 1991 Feb;1(1):124-31. Prog Urol. 1991. PMID: 1285391 French.

5

Prostate cancer in a 75-year-old man after four decades of testicular androgen deprivation.

Boccon-Gibod L, Dauge MC, Billebaud T, Sibert A, Baron JC, Nahoul K. Boccon-Gibod L, et al. Among authors: dauge mc. Eur Urol. 1991;20(1):81-4. doi: 10.1159/000471668. Eur Urol. 1991. PMID: 1743239

6

Prostate-specific antigen density: a means to enhance detection of prostate cancer.

Ramon J, Boccon-Gibod L, Billebaud T, Astier L, Kobelinsky M, Meulemans A, Dauge MC, Boccon-Gibod L, Villers A. Ramon J, et al. Among authors: dauge mc. Eur Urol. 1994;25(4):288-94; discussion 304. doi: 10.1159/000475303. Eur Urol. 1994. PMID: 7519990

7

Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay.

Haab F, Meulemans A, Boccon-Gibod L, Dauge MC, Delmas V, Hennequin C, Benbunan D, Boccon-Gibod L. Haab F, et al. Among authors: dauge mc. Urology. 1995 Jun;45(6):1022-7. doi: 10.1016/s0090-4295(99)80124-1. Urology. 1995. PMID: 7539559 Clinical Trial.

8

A.P.U.D. type endocrine tumour of the prostate. Incidence and prognosis in association with adenocarcinoma.

Dauge MC, Delmas V. Dauge MC, et al. Prog Clin Biol Res. 1987;243A:529-31. Prog Clin Biol Res. 1987. PMID: 2889216 No abstract available.

9

[Intravesical instillations of BCG and bladder carcinoma in situ].

Haab F, Dauge MC, Delmas V, Boccon-Gibod L. Haab F, et al. Among authors: dauge mc. Prog Urol. 1993 Dec;3(6):988-94; discussion 992-3. Prog Urol. 1993. PMID: 8305942 French.

10

Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guérin therapy.

Peyromaure M, Weibing S, Sebe P, Verpillat P, Toublanc M, Dauge MC, Boccon-Gibod L, Ravery V. Peyromaure M, et al. Among authors: dauge mc. Urology. 2002 Mar;59(3):409-13. doi: 10.1016/s0090-4295(01)01551-5. Urology. 2002. PMID: 11880082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters